Shinnihonseiyaku Co., Ltd. AI Stock Analysis
Want to see JP:4931 full AI Analyst Report?
Shinnihonseiyaku Co., Ltd. (4931) AI Stock Analysis
Shinnihonseiyaku Co., Ltd.
(TSE/TYO:4931)
The score is driven primarily by strong financial performance—high margins, improving operating profitability, and a very low-risk balance sheet—partly offset by volatile cash conversion and a steep latest-year free-cash-flow drop. Technicals are moderately positive with price above major moving averages and supportive momentum. Valuation is reasonable with a modest dividend yield, providing additional support.
Shinnihonseiyaku Co., Ltd. (4931) vs. iShares MSCI Japan ETF (EWJ)
- Market Cap
- JPY 43.22B
- Dividend Yield
- 2.89%
- Average Volume (3M)
- 51.26K
- Price to Earnings (P/E)
- 12.3
- Beta (1Y)
- 0.32
- Revenue Growth
- 5.63%
- EPS Growth
- 37.65%
- Country
- Japan
- Employees
- 316
- Sector
- Consumer Cyclical
- Sector Strength
- 61
- Industry
- Specialty Retail
Shinnihonseiyaku Co., Ltd. Business Overview & Revenue Model
Company Description
Shinnihonseiyaku Co., Ltd. is a Japanese-headquartered company, established in 1992, that specializes in providing cosmetics, pharmaceuticals, and health foods both domestically and in international markets. The company's operations are structured in...
How the Company Makes Money
Shinnihonseiyaku makes money primarily by selling its health-related products (e.g., supplements and wellness products) to end customers and through distribution partners, generating revenue from product sales. Key revenue streams typically include (...
Shinnihonseiyaku Co., Ltd. Financial Statement Overview
Summary
Strong profitability and improving operating margin alongside steady revenue growth support a high score. The balance sheet is exceptionally conservative with near-zero leverage, reducing financial risk. The main offset is uneven cash conversion and a sharp free-cash-flow decline in the latest year despite remaining positive.
Income Statement
82Very PositiveBalance Sheet
93Very PositiveCash Flow
68Positive| Breakdown | TTM | Sep 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.56B | 43.45B | 41.14B | 40.04B | 37.65B | 36.11B |
| Gross Profit | 33.55B | 34.09B | 32.58B | 31.53B | 29.98B | 29.07B |
| EBITDA | 4.96B | 5.50B | 5.15B | 4.49B | 4.19B | 3.95B |
| Net Income | 3.29B | 3.51B | 2.55B | 2.79B | 2.39B | 2.36B |
Balance Sheet | ||||||
| Total Assets | 29.03B | 30.08B | 28.44B | 27.28B | 25.50B | 23.86B |
| Cash, Cash Equivalents and Short-Term Investments | 18.59B | 19.47B | 18.12B | 16.34B | 15.52B | 14.35B |
| Total Debt | 349.00M | 0 | 76.00M | 253.00M | 446.00M | 1.84B |
| Total Liabilities | 4.79B | 5.13B | 5.63B | 5.48B | 5.84B | 5.94B |
| Stockholders Equity | 24.24B | 24.95B | 22.81B | 21.79B | 19.66B | 17.92B |
Cash Flow | ||||||
| Free Cash Flow | 4.63B | 2.60B | 4.63B | 1.93B | 3.37B | 2.25B |
| Operating Cash Flow | 4.69B | 2.73B | 4.69B | 2.10B | 3.47B | 2.29B |
| Investing Cash Flow | -1.79B | -1.73B | -1.79B | -382.00M | -208.00M | -496.00M |
| Financing Cash Flow | -2.10B | -1.18B | -2.10B | -902.00M | -2.10B | -1.09B |
Shinnihonseiyaku Co., Ltd. Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4931, the sentiment is Positive. The current price of 2040.00 is above the 20-day moving average (MA) of 2004.55, above the 50-day MA of 1992.84, and above the 200-day MA of 1974.27, indicating a bullish trend. The MACD of 9.01 indicates Negative momentum. The RSI at 56.18 is Neutral, neither overbought nor oversold. The STOCH value of 62.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4931.
Shinnihonseiyaku Co., Ltd. Peers Comparison
Overall Rating
- JP:493180Outperform
JP:219A75.8Outperform
JP:767969Neutral
JP:334959.9Neutral
JP:279643Neutral
JP:190A32Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| JP:4931 | 80Outperform | JPY 43.86B | 12.31 | ― | 2.89% | 5.63% | 37.65% |
| JP:219A | 76Outperform | JPY 66.61B | -98.40 | ― | ― | ― | ― |
| JP:7679 | 69Neutral | JPY 30.36B | 8.06 | ― | 1.89% | 8.08% | -15.52% |
| Sector * | 61Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |
| JP:3349 | 60Neutral | JPY 505.70B | 15.88 | ― | 1.27% | 8.99% | 3.61% |
| JP:2796 | 43Neutral | JPY 5.96B | 59.72 | ― | 2.76% | 7.64% | ― |
| JP:190A | 32Underperform | JPY 3.54B | -2.33 | ― | ― | ― | 24.21% |
* Consumer Cyclical Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| JP:4931 | Shinnihonseiyaku Co., Ltd. | 2040.00 | -13.07 | -0.64% | |
| JP:2796 | Pharmarise Holdings Corp. | 507.00 | -18.84 | -3.58% | |
| JP:3349 | COSMOS Pharmaceutical Corporation | 6437.00 | -929.03 | -12.61% | |
| JP:7679 | Yakuodo Holdings Co., Ltd. | 1546.00 | -545.36 | -26.08% | |
| JP:190A | Chordia Therapeutics Inc. | 46.00 | -61.00 | -57.01% | |
| JP:219A | Heartseed, Inc. | 2885.00 | 1165.00 | 67.73% |
Shinnihonseiyaku Co., Ltd. Corporate Events
Shinnihonseiyaku Reports Fiscal 2026 Sales and Profit Growth
Shinnihonseiyaku is engaged in healthcare and cosmetics businesses, with Slimore Coffee and Fun and Health among the products or brands named in the release.For the fiscal year ended September 2026, net sales rose 5.6% year over year to ¥43,455 milli...
Shinnihonseiyaku Reports Fiscal 2026 Sales and Profit Growth
Shinnihonseiyaku Co., Ltd. reported consolidated results for the fiscal year ended September 30, 2026, with net sales of ¥43,455 million, up 5.6% year on year. Operating profit rose 8.2% to ¥5,176 million, ordinary profit increased 6.7% to ¥5,202 mil...
Shinnihonseiyaku Reports Fiscal 2026 Growth, Raises Year-End Dividend Forecast
Shinnihonseiyaku reported fiscal-year net sales of ¥43,450 million, operating profit of ¥5,257 million, ordinary profit of ¥5,294 million and net profit of ¥3,300 million for the year ended September 30, 2026. Compared with the previous fiscal year,...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 14, 2026